Страна: Израел
Език: английски
Източник: Ministry of Health
MUPIROCIN AS CALCIUM
GLAXO SMITH KLINE (ISRAEL) LTD
R01AX06
OINTMENT
MUPIROCIN AS CALCIUM 2 %W/W
NASAL
Required
GLAXO OPERATIONS (UK) LIMITED
MUPIROCIN
MUPIROCIN
The elimination of nasal carriage of staphylococci, including methycillin-resistant staphylococus aureus (MRSA).
2020-09-30
PATIENT PACKAGE INSERT IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS (PREPARATIONS) - 1986 The medicine is dispensed with a physician's prescription only BACTROBAN NASAL OINTMENT EACH GRAM CONTAINS 20 MG MUPIROCIN (AS CALCIUM) (2% W/W) For a list of the inactive and allergenic ingredients in the preparation, see section 6 – "Additional information". READ THE LEAFLET CAREFULLY IN ITS ENTIRETY BEFORE USING THE MEDICINE. This leaflet contains concise information about the medicine. If you have further questions, refer to the physician or pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if it seems to you that their medical condition is similar. 1. WHAT IS THE MEDICINE INTENDED FOR? Bactroban Nasal contains an active ingredient called mupirocin calcium. It is used: • To kill a group of bacteria in the nose called ׳ Staphylococci' • This group includes methicillin-resistant Staphylococcus aureus (MRSA) • This ointment is intended for use in your nose only. THERAPEUTIC GROUP: Antibiotic for topical use. 2. BEFORE USING THE MEDICINE DO NOT USE THE MEDICINE IF: • You are sensitive (allergic) to mupirocin calcium, mupirocin or any of the additional ingredients contained in the medicine (as detailed in section 6 "Additional information"). If you are not sure if this applies to you, do not use this medicine. Refer to your physician or pharmacist before using Bactroban Nasal. SPECIAL WARNINGS REGARDING USE OF THE MEDICINE Bactroban Nasal can cause allergies or severe skin reactions. See 'Conditions to look out for' in Section 4. Do not use this medicine frequently, or for a prolonged period, without consulting a physician. Thrush (a yeast infection) may develop if Bactroban Nasal is used for a long time. If this occurs, tell your physician or pharmacist. Keep the ointment away from the eyes. - If the ointment gets into your eyes accidentally, wash them thoroughly with water. DRUG INTERACTIONS IF YOU ARE TAKING OR HAVE RECENTLY TAKEN OTHER MEDICINES, INC Прочетете целия документ
_ _ Page 1 of 6 BACTROBAN NASAL 1. NAME OF THE MEDICINAL PRODUCT Bactroban Nasal 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each gram of nasal ointment contains mupirocin calcium equivalent to 20 mg mupirocin (2% w/w mupirocin free acid). 3. PHARMACEUTICAL FORM White soft paraffin based nasal ointment containing a glycerin ester. Off-white smooth ointment. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS The elimination of nasal carriage of staphylococci, including methicillin resistant S _taphylococcus aureus_ (MRSA). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _Dosage: _ _Adults (including the elderly_ _/renally impaired/hepatically impaired_ _) and _ _children: _ _ _ _ _ Apply a small quantity of Mupirocin nasal ointment , about the size of a match head (approximately 30 mg of ointment) to each nostril twice a day for at least 5 days. _Method of Administration: _ Use a cotton tipped applicator. After application, the nostrils should be closed by pressing the sides of the nose together several times. Nasal carriage should normally be clear within three to five days of treatment. Dosage should not exceed ten days. Do not mix with other preparations as there is a risk of dilution, resulting in a reduction in the antibacterial activity and potential loss of stability of the mupirocin in the ointment. 4.3 CONTRAINDICATIONS _ _ Page 2 of 6 Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Should a possible sensitisation reaction or severe local irritation occur with the use of Bactroban Nasal Ointment, treatment should be discontinued, the product should be wiped away and appropriate therapy instituted. As with other antibacterial products, prolonged use may result in overgrowth of non- susceptible organisms. Pseudomembranous colitis has been reported with the use of antibiotics and may range in severity from mild to life-threatening. Therefore, it is important to consider its diagnosis in patients who develop diarrhoea during o Прочетете целия документ